Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE-HF trial.
Constantinos BakogiannisDimitrios MouselimisAnastasios TsarouchasChristodoulos E PapadopoulosEfstratios K TheofillogiannakosElmira LechatAntonios P AntoniadisEfstathios D PagoureliasIoannis KelemanisStergios TzikasNikolaos FragakisGeorgios K EfthimiadisTheodoros D KaramitsosMichael DoumasVassilios P VassilikosPublished in: ESC heart failure (2023)
The RESAFE-HF trial is expected to provide evidence on the effect of treating ID with FCM in HFrEF based on real-world data. Special focus will be given on the arrhythmic burden post-FCM administration.